top of page

FDA developing new rules for artificial intelligence in medicine



The Food and Drug Administration announced Tuesday that it is developing a framework for regulating artificial intelligence products used in medicine that continually adapt based on new data.


The agency’s outgoing commissioner, Scott Gottlieb, released a white paper that sets forth the broad outlines of the FDA’s proposed approach to establishing greater oversight over this rapidly evolving segment of AI products.



source STAT

6 views0 comments

Recent Posts

See All

Medtech industry outlook 2021

Dear all, here are the great sources that caught our eye in the last weeks regarding the medical device industry outlook as of 2021. Including: - EY report, 2021 - McKinsey report, 2021 - MedTech Dive

bottom of page